110 related articles for article (PubMed ID: 8157271)
21. Epitope mapping of the V3 domain of feline immunodeficiency virus envelope glycoprotein by monoclonal antibodies.
Lombardi S; Massi C; Tozzini F; Zaccaro L; Bazzichi A; Bandecchi P; La Rosa C; Bendinelli M; Garzelli C
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1893-9. PubMed ID: 7636470
[TBL] [Abstract][Full Text] [Related]
22. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope.
Richardson J; Fossati I; Moraillon A; Castelot S; Sonigo P; Pancino G
J Gen Virol; 1996 Apr; 77 ( Pt 4)():759-71. PubMed ID: 8627265
[TBL] [Abstract][Full Text] [Related]
23. Characterization of rat NCA/CD9 cell surface antigen and its expression by normal and malignant neural cells.
Deissler H; Blass-Kampmann S; Kindler-Röhrborn A; Meyer HE; Rajewsky MF
J Neurosci Res; 1996 Mar; 43(6):664-74. PubMed ID: 8984196
[TBL] [Abstract][Full Text] [Related]
24. Identification of the feline CD63 homologue using retrovirus-mediated expression cloning.
Sakurai Y; Shimojima M; Miyazawa T; Masuoka K; Tohya Y; Akashi H
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):185-91. PubMed ID: 15010227
[TBL] [Abstract][Full Text] [Related]
25. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.
de Parseval A; Ngo S; Sun P; Elder JH
J Virol; 2004 Sep; 78(17):9132-43. PubMed ID: 15308709
[TBL] [Abstract][Full Text] [Related]
26. Expression of CXCR4 in the brain of feline immunodeficiency virus infected cat.
Koirala TR; Sharma S; Morikawa S; Ishida T
Indian J Pathol Microbiol; 2000 Jul; 43(3):285-90. PubMed ID: 11218674
[TBL] [Abstract][Full Text] [Related]
27. Differential CXCR4 expression and function in subpopulations of the feline lymphoma cell line 3201 susceptible to feline immunodeficiency virus.
Tochikura TS; Motokawa K; Naito Y; Kozutsumi Y; Tanabe-Tochikura A; Hohdatsu T
J Feline Med Surg; 2010 Apr; 12(4):269-77. PubMed ID: 19896878
[TBL] [Abstract][Full Text] [Related]
28. Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus.
Willett BJ; McMonagle EL; Bonci F; Pistello M; Hosie MJ
J Virol; 2006 Aug; 80(15):7744-7. PubMed ID: 16840353
[TBL] [Abstract][Full Text] [Related]
29. Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits.
Westman ME; Malik R; Hall E; Sheehy PA; Norris JM
Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():43-52. PubMed ID: 26459979
[TBL] [Abstract][Full Text] [Related]
30. Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone.
Miyazawa T; Kawaguchi Y; Kohmoto M; Sakuragi J; Adachi A; Fukasawa M; Mikami T
J Gen Virol; 1992 Jun; 73 ( Pt 6)():1543-6. PubMed ID: 1318947
[TBL] [Abstract][Full Text] [Related]
31. A feline homologue of CD1 is defined using a feline-specific monoclonal antibody.
Woo JC; Moore PF
Tissue Antigens; 1997 Mar; 49(3 Pt 1):244-51. PubMed ID: 9098931
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a feline homologue of the alphaE integrin subunit (CD103) reveals high specificity for intra-epithelial lymphocytes.
Woo JC; Roccabianca P; van Stijn A; Moore PF
Vet Immunol Immunopathol; 2002 Feb; 85(1-2):9-22. PubMed ID: 11867163
[TBL] [Abstract][Full Text] [Related]
33. The generation of monoclonal antibodies recognising novel epitopes by immunisation with solid matrix antigen-antibody complexes reveals a polymorphic determinant on feline CD4.
Willett BJ; de Parseval A; Peri E; Rocchi M; Hosie MJ; Randall R; Klatzmann D; Neil JC; Jarrett O
J Immunol Methods; 1994 Dec; 176(2):213-20. PubMed ID: 7527069
[TBL] [Abstract][Full Text] [Related]
34. Distribution of cell surface glycoprotein CD9 (P24) antigen on megakaryocyte lineage leukemias and cell lines.
Imamura N; Mtasiwa DM; Ota H; Inada T; Kuramoto A
Am J Hematol; 1990 Sep; 35(1):65-7. PubMed ID: 2389771
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and histochemical characterization of a murine tubular antigen.
Davis ID; LeBien TW; Lindman BJ; Platt JL
J Am Soc Nephrol; 1991 Apr; 1(10):1153-61. PubMed ID: 1768810
[TBL] [Abstract][Full Text] [Related]
36. Quantitative membrane proteomics reveals a role for tetraspanin enriched microdomains during entry of human cytomegalovirus.
Viswanathan K; Verweij MC; John N; Malouli D; Früh K
PLoS One; 2017; 12(11):e0187899. PubMed ID: 29121670
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of membrane proteins of vero cells: exploration of potential proteins responsible for virus entry.
Guo D; Zhu Q; Zhang H; Sun D
DNA Cell Biol; 2014 Jan; 33(1):20-8. PubMed ID: 24286161
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical distribution of the tetraspanin CD9 in normal porcine tissues.
Yubero N; Jiménez-Marín A; Lucena C; Barbancho M; Garrido JJ
Mol Biol Rep; 2011 Feb; 38(2):1021-8. PubMed ID: 20585885
[TBL] [Abstract][Full Text] [Related]
39. Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections.
Hassuna N; Monk PN; Moseley GW; Partridge LJ
BioDrugs; 2009; 23(6):341-59. PubMed ID: 19894777
[TBL] [Abstract][Full Text] [Related]
40. Widespread balancing selection and pathogen-driven selection at blood group antigen genes.
Fumagalli M; Cagliani R; Pozzoli U; Riva S; Comi GP; Menozzi G; Bresolin N; Sironi M
Genome Res; 2009 Feb; 19(2):199-212. PubMed ID: 18997004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
